Skip to content

Preemptive Analgesic Effects of Rectus Sheath Block in Laparoscopic Cholecystectomy Patients

The Effectiveness of Preemptive Effect of Rectus Sheath Block and Intercostal Block on Postoperative Visceral Pain in Laparoscopic Cholecystectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03413280
Enrollment
200
Registered
2018-01-29
Start date
2017-03-28
Completion date
2018-01-15
Last updated
2019-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preemptive Peripheral Nerve Block, Pain, Postoperative, Acute Pain

Keywords

preemptive analgic effect, Rectus Sheath Block, laparoscopic cholecystectomy

Brief summary

The purpose of this study was to investigate the effectiveness of preemptive effect of rectus sheath block (RSB) and intercostal nerve block (ICNB) on postoperative visceral pain in laparoscopic cholecystectomy (LLC). After induction of general anesthesia, group of patient is decided randomly. In Group pre, RSB and ICNB are performed with 0.25% Ropivacaine 40ml before the operation. In Group post, RSB and ICNB are performed with 0.25% Ropivacaine 40ml after the operation. Measure the NRS and compare the rescue analgesic dose used at 0, 0.5, 1, 2, 6, 9, 18, and 24 hours after arrival at the recovery room.

Interventions

Ultrasound guided rectus sheath block with 0.25% ropivacaine 34ml around umbilicus

Ultrasound guided intercostal nerve block with 0.25% ropivacaine 6ml in 7,8,9 th intercostal space

Sponsors

Asan Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. adults between the ages of 20 and 80 2. scheduled laparoscopic cholecystectomy patient 3. ASA class 1 or 2 4. Patients who have voluntarily agreed in writing to participate in the trial

Exclusion criteria

1. Patient with side effects on local anesthetics or steroids 2. Patient who are taboo of peripheral nerve block such as blood clotting disorder, infection, etc. 3. Patients with uncontrolled medical or psychiatric problem 4. Patient does not agree to participate in the study 5. Patients who are pregnant or lactating 6. Patients whose visceral pain is expected to be too severe 7. Patients receiving a single laparoscopic cholecystectomy (including using a robot)

Design outcomes

Primary

MeasureTime frameDescription
Difference of analgesic consumption between both groupat 0, 0.5, 1, 2, 6, 9, 18, 24 hours after operationThe difference in analgesics usage between the two groups after the operation is checked at fixed intervals (at 0, 0.5, 1, 2, 6, 9, 18, 24 hours after operation) to compare.

Secondary

MeasureTime frameDescription
compare the Numeric rating scale (NRS)at 0, 0.5, 1, 2, 6, 9, 18, 24 hours after operationThe Numeric Rating Scale (NRS-11) is an 11-point scale for patient self-reporting of pain. It is for adults and children 10 years old or older. 0: No pain, 1-3: mild pain, 4-6: Moderate pain, 7-10: severe pain, 10: worst pain imaginable. After surgery, the NRS differences between the two groups were compared at a constant interval (0, 0.5, 1, 2, 6, 9, 18, 24 hours postoperatively).

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026